'Option B+' women are at increased risk of loss to follow-up after starting HIV treatment
Kidney problems linked to tenofovir use, improve with switch to abacavir
Stigma, delay and misunderstanding slow access to ART in Africa
Scientists and clinicians must challenge HIV-related stigma and ensure enabling legal and policy environments, IAS conference hears
Efavirenz in children: WHO dosing guidelines raise the risk of side-effects in Thai children
Non-African middle-income countries pay four times more for ARVs than African middle-income countries
Darunavir/ritonavir safe and effective for younger children
Lower-dose lopinavir/ritonavir reduces side-effects, maintains viral control in Thai children
